Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

News Industry News

Intact Vascular Announces Positive Six-Month Data from TOBA II BTK Clinical Trial During Late-Breaking Session at 2019 VIVA Conference

November 06, 2019

News Daily News

For Percutaneous LVADs, Vascular Complications Decreasing but Still Common

Caitlin E. Cox

November 06, 2019

News Daily News

Novel Japanese CTO Algorithm Prompts Potential for a More Global Strategy

Yael L. Maxwell

November 05, 2019

News Industry News

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

September 27, 2019

Presentation TCT 2019

TOBA III: 1-Year Outcomes From a Single-Arm Study of Focal Dissection Repair After Drug-Coated Balloon Angioplasty of Superficial Femoral And Proximal Popliteal Arteries

Presenter: Marianne Brodmann

September 27, 2019

News Industry News

Intact Vascular Announces US Launch of the Tack Endovascular System® and First Commercial Use

May 07, 2019

News Features

Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option?

Shelley Wood

April 30, 2019

News Industry News

Intact Vascular’s Tack Endovascular System® Receives FDA Approval

April 16, 2019

News Daily News

Majority of SCAD Lesions Heal With Conservative Treatment

Michael O'Riordan

February 27, 2019

Advertisement

Intact Vascular Announces Positive Six-Month Data from TOBA II BTK Clinical Trial During Late-Breaking Session at 2019 VIVA Conference

For Percutaneous LVADs, Vascular Complications Decreasing but Still Common

Novel Japanese CTO Algorithm Prompts Potential for a More Global Strategy

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

TOBA III: 1-Year Outcomes From a Single-Arm Study of Focal Dissection Repair After Drug-Coated Balloon Angioplasty of Superficial Femoral And Proximal Popliteal Arteries

Intact Vascular Announces US Launch of the Tack Endovascular System® and First Commercial Use

Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option?

Intact Vascular’s Tack Endovascular System® Receives FDA Approval

Majority of SCAD Lesions Heal With Conservative Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content